Table 2 In-hospital adverse events of the study cohort
Variables | Overall (n = 1401) | Patients with thrombocytopenia (n = 186) | Patients without thrombocytopenia (n = 1215) | p value |
|---|---|---|---|---|
In-hospital infection, n (%) | 254 (18.1%) | 57 (30.6%) | 197 (16.2%) | < 0.001 |
Type of infections, n (%) | Â | Â | Â | 0.804 |
 Pulmonary infection | 199 (78.3%) | 43 (75.4%) | 156 (79.2%) |  |
 Urinary infection | 33 (13.0%) | 8 (14.0%) | 25 (12.7%) |  |
 Other infections | 22 (8.7%) | 6 (10.5%) | 16 (8.1%) |  |
MACE, n (%) | 255 (18.2%) | 56 (30.1%) | 199 (16.4%) | < 0.001 |
In-hospital death, n (%) | 61 (4.4%) | 15 (8.1%) | 46 (3.8%) | 0.008 |
Hospital day (d) | 8.82 ± 7.40 | 11.41 ± 10.17 | 8.43 ± 6.80 | < 0.001 |